1. Alexiou C, Kau RJ, Dietzfelbinger H, Kremer M, Spiess JC, Schratzenstaller B, et al. Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts. Cancer. 1999; 85:2305–2314.
2. Bataille R, Sany J. Solitary myeloma: clinical and prognostic features of a review of 114 cases. Cancer. 1981; 48:845–851.
3. Masood A, Hudhud KH, Hegazi A, Syed G. Mediastinal plasmacytoma with multiple myeloma presenting as a diagnostic dilemma. Cases J. 2008; 1:116.
4. Lee SY, Kim JH, Shin JS, Shin C, In KH, Kang KH, et al. A case of extramedullary plasmacytoma arising from the posterior mediastinum. Korean J Intern Med. 2005; 20:173–176.
5. Ganesh M, Sankar NS, Jagannathan R. Extramedullary plasmacytoma presenting as upper back pain. J R Soc Promot Health. 2000; 120:262–265.
6. Montero C, Souto A, Vidal I, Fernandez Mdel M, Blanco M, Verea H. Three cases of primary pulmonary plasmacytoma. Arch Bronconeumol. 2009; 45:564–566.
7. Oriol A. Multiple myeloma with extramedullary disease. Adv Ther. 2011; 28:Suppl 7. 1–6.
8. Moran CA, Suster S, Fishback NF, Koss MN. Extramedullary plasmacytomas presenting as mediastinal masses: clinicopathologic study of two cases preceding the onset of multiple myeloma. Mod Pathol. 1995; 8:257–259.
9. Husain M, Nguyen GK. Primary pulmonary plasmacytoma diagnosed by transthoracic needle aspiration cytology and immunocytochemistry. Acta Cytol. 1996; 40:622–624.
10. Agarwal PP, Seely JM, Matzinger FR. Case 130: mediastinal hemangioma. Radiology. 2008; 246:634–637.
11. Mohammad Taheri Z, Mohammadi F, Karbasi M, Seyfollahi L, Kahkoei S, Ghadiany M, et al. Primary pulmonary plasmacytoma with diffuse alveolar consolidation: a case report. Patholog Res Int. 2010; 2010:463465.
12. Horiuchi T, Hirokawa M, Oyama Y, Kitabayashi A, Satoh K, Shindoh T, et al. Diffuse pulmonary infiltrates as a roentgenographic manifestation of primary pulmonary plasmacytoma. Am J Med. 1998; 105:72–74.
13. Palumbo A, Sezer O, Kyle R, Miguel JS, Orlowski RZ, Moreau P, et al. International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation. Leukemia. 2009; 23:1716–1730.
14. Chen HF, Wu TQ, Li ZY, Shen HS, Tang JQ, Fu WJ, et al. Extramedullary plasmacytoma in the presence of multiple myeloma: clinical correlates and prognostic relevance. Onco Targets Ther. 2012; 5:329–334.